[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-356160-en":3,"detail-sidebar-cat-0-en-105":51,"doc-seo-356160-105":98},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":20,"is_deleted":4,"is_public":21,"is_downloadable":21,"audit_status":21,"page_count":22,"language":23,"language_code":24,"site_id":25,"html_lang":24,"table_of_contents":26,"faqs":27,"seo_title":28,"seo_description":14,"update_tm":29,"read_time":30,"preview_page_count":31,"preview_urls":32},356160,962090894170,"CatatanPagi","https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8",8,"Research & Report","Current progress and future prospects of chlorin e6 (Ce6) as a therapeutic agent","Photodynamic therapy (PDT) offers a localized, noninvasive anticancer strategy by using a photosensitizer to generate cytotoxic reactive oxygen species (ROS). This review focuses on chlorin e6 (Ce6), a second-generation, FDA-approved photosensitizer widely used for strong anticancer activity and high ROS generation across multiple cancer types. The work evaluates Ce6’s therapeutic potential, summarizes the current research landscape, and highlights key obstacles affecting clinical translation, including limitations linked to tumor hypoxia and PDT mechanisms.","RSC Advances  \nREVIEW  \nPublished on 07 September 2026 Licensed under CC-BY-NC 4.0  \nCite this: DOI: 10 .1039/d6ra04753j  \nReceived 1st June 2026  \nAccepted 1st September 2026 DOI: 10.1039/d6ra04753j[rsc.li/rsc-advances](rsc.li/rsc-advances)  \nCurrent progress and future prospects of chlorin e6 (Ce6) as a therapeutic agent  \nAishat Adejoke Obalola, Heidi Abrahamse  and Sathish Sundar Dhilip Kumar  *  \nTraditional cancer treatment approaches can have serious side eﬀects and signiﬁcant therapeutic limits. Because photodynamic therapy is eﬀective against a variety of cancer types and has few side eﬀects, it has changed the course of cancer research. Photodynamic therapy is a localized, noninvasive treatment. The essential element of photodynamic therapy (PDT), which produces cytotoxic reactive oxygen species that are harmful to cancer cells, is a photosensitizer. A lot of work has gone into ﬁnding the perfect photosensitizer, since PDT's therapeutic eﬃcacy largely depends on it. Chlorin e6, a secondgeneration photosensitizer with FDA approval that meets the clinical requirements for PDT, is the most widely used. It is well known for its strong anticancer activity across many cancer types and its high capacity to generate reactive oxygen species (ROS) . The present study examines the therapeutic potential, research status, and obstacles associated with the clinical use of Ce6 .  \n1. Introduction  \nAccording to reports, cancer continues to rank among the leading causes of mortality and serious illness worldwide.1 Surgery, a common therapy for cancer, is painful to the human body and is ineﬀective at removing unseen tumours.2 On healthy tissues and organs, radiation treatment and chemotherapy have major toxic side eﬀects, and tumour cells are prone to tolerance, signi􀀁cantly reducing therapeutic eﬃcacy.3 Over the last several years, a number of novel anticancer treatments have been produced to address these issues.4 Among them, photodynamic therapy (PDT) may cause permanent oxidative damage to tumour cells by activating photosensitizersin the tumour region, thereby producing a signi􀀁cant number of reactive oxygen species.5 In the nonilluminated region, PDT signi􀀁cantly lowers toxicity and adverse eﬀects while being more deadly to the tumour.6 PDT also bene􀀁ts from multicourse therapy, since tumour cells are largely resistant to photosensitive medications.7 PDT typically involves the absorption of light by a photosensitizer, thereby stimulating the generation of harmful reactive oxygen species (ROS) . Nevertheless, the majority of PDT used today employs an O2-dependent type II photoreaction mechanism that generates singlet oxygen (1O2) by transferring energy from excited photosensitizers to O2 molecules, thereby destroying tumour cells. Unfortunately, the hypoxic microenvironment of solid tumours signi􀀁cantly reduces the therapeutic eﬀectiveness of PDT. The use of oxygen will worsen hypoxia and lead to the development and spread of tumours. To alleviate tumour hypoxia, a number of  \nLaser Research Centre, University of Johannesburg, P. O. Box 17011, Doornfontien, Johannesburg, 2028, South Africa. E-mail: [sathishd@uj.ac.za](sathishd@uj.ac.za)  \nnanoplatforms that supply or generate O2 in situ have been investigated. Nevertheless, the nanoplatform's diﬃcult construction and ineﬃcient O2 supply cannot address the underlying issues. On the other hand, hypoxia-tolerant type IPDT is less reliant on the O2 level and produces radical species (such as superoxide (O2 c −) and hydroxyl (cOH) radicals) by electron transfer from excited photosensitizers to substrateseven in hypoxic settings. Therefore, the development of type Iphotosensitizers to improve the eﬀectiveness of hypoxic-tumor PDT is highly desirable.8  \nVarious photosensitizers have been developed and manufactured in recent years to meet the requisite photophysical and biological properties; some have even received clinical approval.9 Compared with traditional photosensitizers, chlor","cbCaifC4WNjbmtWg","https://ap.wps.com/l/cbCaifC4WNjbmtWg","pdf",1452890,7,1,24,"English","en",105,"# Introduction\n## Photodynamic therapy\n## Chlorin e6 (Ce6) as a photosensitizer\n## Progress in Ce6-based therapeutic applications\n## Obstacles and future prospects","[{\"question\":\"Why is photodynamic therapy considered an effective cancer treatment?\",\"answer\":\"PDT is effective against many cancer types and has few side effects because it is localized and noninvasive. It relies on a photosensitizer to generate cytotoxic reactive oxygen species that harm cancer cells.\"},{\"question\":\"What role does Ce6 play in photodynamic therapy?\",\"answer\":\"Ce6 is a second-generation photosensitizer with FDA approval that is widely used in PDT. It is known for strong anticancer activity and high capacity to generate ROS.\"},{\"question\":\"What challenges limit the clinical effectiveness of PDT?\",\"answer\":\"The hypoxic microenvironment of solid tumors reduces PDT effectiveness, and oxygen use can worsen hypoxia. The review also discusses the need for photosensitizers and strategies that can overcome these mechanistic limitations.\"}]","Current progress and future prospects of chlorin e6 (Ce6) as a therapeutic agent | PDF",1790123736,60,4,[33,37,42,47],{"page_no":21,"url":34,"width":35,"height":36},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7edba0ccc4c3e215e7081cb54e9448fd.webp",983,1287,{"page_no":38,"url":39,"width":40,"height":41},2,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1355f6bc436cb097b75a5e395db41002.webp",982,1286,{"page_no":43,"url":44,"width":45,"height":46},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6af171ecea842b1ebb20e926b9b4daf7.webp",981,1284,{"page_no":31,"url":48,"width":49,"height":50},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a730c472b8a6e5d6ac79753ee27d3d5b.webp",980,1283,{"code":4,"msg":5,"data":52},[53,58,62,66,70,75,79,82,87,90,94],{"id":21,"doc_module":4,"doc_module_name":54,"category_name":55,"show_sort_weight":56,"slug":57},"Document","Story & Novel",90,"story-novel",{"id":38,"doc_module":4,"doc_module_name":54,"category_name":59,"show_sort_weight":60,"slug":61},"Literature",80,"literature",{"id":31,"doc_module":4,"doc_module_name":54,"category_name":63,"show_sort_weight":64,"slug":65},"Exam",70,"exam",{"id":67,"doc_module":4,"doc_module_name":54,"category_name":68,"show_sort_weight":30,"slug":69},5,"Comic","comic",{"id":71,"doc_module":4,"doc_module_name":54,"category_name":72,"show_sort_weight":73,"slug":74},6,"Technology",50,"technology",{"id":20,"doc_module":4,"doc_module_name":54,"category_name":76,"show_sort_weight":77,"slug":78},"Healthcare",40,"healthcare",{"id":11,"doc_module":4,"doc_module_name":54,"category_name":12,"show_sort_weight":80,"slug":81},30,"research-report",{"id":83,"doc_module":4,"doc_module_name":54,"category_name":84,"show_sort_weight":85,"slug":86},9,"Religion & Spirituality",20,"religion-spirituality",{"id":85,"doc_module":4,"doc_module_name":54,"category_name":88,"show_sort_weight":85,"slug":89},"World Cup","world-cup",{"id":91,"doc_module":4,"doc_module_name":54,"category_name":92,"show_sort_weight":91,"slug":93},10,"Lifestyle","lifestyle",{"id":95,"doc_module":4,"doc_module_name":54,"category_name":96,"show_sort_weight":67,"slug":97},19,"General","general",{"code":4,"msg":99,"data":100},"ok",{"site_id":25,"language":24,"slug":101,"title":13,"keywords":102,"description":14,"schema_data":103,"social_meta":156,"head_meta":158,"extra_data":160,"updated_unix":161},"current-progress-and-future-prospects-of-chlorin-e6-ce6-as-a-therapeutic-agent","",{"@graph":104,"@context":155},[105,118,138],{"@type":106,"itemListElement":107},"BreadcrumbList",[108,112,114,116],{"item":109,"name":110,"@type":111,"position":21},"https://docshare.wps.com","Home","ListItem",{"item":113,"name":54,"@type":111,"position":38},"https://docshare.wps.com/document/",{"item":115,"name":12,"@type":111,"position":43},"https://docshare.wps.com/document/research-report/",{"item":117,"name":13,"@type":111,"position":31},"https://docshare.wps.com/document/current-progress-and-future-prospects-of-chlorin-e6-ce6-as-a-therapeutic-agent/356160/",{"url":117,"name":13,"@type":119,"image":120,"author":125,"headline":13,"publisher":127,"fileFormat":130,"inLanguage":24,"description":14,"dateModified":131,"datePublished":132,"encodingFormat":130,"isAccessibleForFree":133,"interactionStatistic":134},"DigitalDocument",{"url":121,"@type":122,"width":123,"height":124},"https://docshare.wps.com/thumbnails/current-progress-and-future-prospects-of-chlorin-e6-ce6-as-a-therapeutic-agent/356160.png","ImageObject",300,407,{"name":9,"@type":126},"Person",{"url":109,"name":128,"@type":129},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":135,"interactionType":136,"userInteractionCount":20},"InteractionCounter",{"@type":137},"ViewAction",{"@type":139,"mainEntity":140},"FAQPage",[141,147,151],{"name":142,"@type":143,"acceptedAnswer":144},"Why is photodynamic therapy considered an effective cancer treatment?","Question",{"text":145,"@type":146},"PDT is effective against many cancer types and has few side effects because it is localized and noninvasive. It relies on a photosensitizer to generate cytotoxic reactive oxygen species that harm cancer cells.","Answer",{"name":148,"@type":143,"acceptedAnswer":149},"What role does Ce6 play in photodynamic therapy?",{"text":150,"@type":146},"Ce6 is a second-generation photosensitizer with FDA approval that is widely used in PDT. It is known for strong anticancer activity and high capacity to generate ROS.",{"name":152,"@type":143,"acceptedAnswer":153},"What challenges limit the clinical effectiveness of PDT?",{"text":154,"@type":146},"The hypoxic microenvironment of solid tumors reduces PDT effectiveness, and oxygen use can worsen hypoxia. The review also discusses the need for photosensitizers and strategies that can overcome these mechanistic limitations.","https://schema.org",{"og:url":117,"og:type":157,"og:title":13,"og:site_name":128,"og:description":14},"article",{"robots":159,"canonical":117},"index,follow",{"doc_id":7,"site_id":25},1790839988]